CENTRAL PHARMACEUTICAL CPC1.JSC

CENTRAL PHARMACEUTICAL CPC1.JSC (CÔNG TY CỔ PHẦN DƯỢC PHẨM TRUNG ƯƠNG CPC1) is a long-established pharmaceutical distributor headquartered in Hanoi, operating at the core of Vietnam’s drug distribution and medical supply network. Founded in 2010, the company is a joint-stock company with state-related ownership, is listed on UPCoM under the ticker DP1, and serves as a stable intermediary between manufacturers, hospitals, pharmacies, and healthcare institutions nationwide.

CENTRAL PHARMACEUTICAL CPC1.JSC maintains a solid operational scale. By the end of 2024, total assets reached approximately USD 57.2 million, while equity strengthened to about USD 21.0 million, reflecting steady capital accumulation. Although revenue declined slightly to approximately USD 83.2 million amid a more competitive pharmaceutical distribution market, profitability improved, with net profit rising to approximately USD 4.7 million. This divergence highlights improving margins, tighter cost control, and a more disciplined operating structure rather than volume-driven growth.

From a governance and risk perspective, the company benefits from experienced leadership under Chairwoman HAN T. K. V., supported by an executive team with deep sector knowledge. Working capital of nearly USD 14.9 million provides a comfortable liquidity buffer, supporting inventory turnover and receivables management in a sector where payment cycles can be lengthy. Overall, CENTRAL PHARMACEUTICAL CPC1.JSC stands out as a financially resilient, mid-scale pharmaceutical distributor, prioritizing balance-sheet strength and profitability over aggressive expansion. This profile appeals to banks, suppliers, and long-term business partners seeking stability in Vietnam’s healthcare supply chain.